Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
60

Summary

Conditions
  • Acute Myelogenous Leukemia
  • B-cell Acute Lymphoblastic Leukemia
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Chronic Myeloid Leukemia, Blast Crisis
Type
Interventional
Phase
Phase 1
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02730312
Collaborators
ICON Clinical Research
Investigators
Study Director: Allen S. Yang, MD, PhD Senior VP & Chief Medical Officer, Xencor, Inc.